Search Results | Showing 251 - 260 of 279 results for "Abbott" |
| | | ... quarter's top performing funds were Lazard's Australian Equity Fund, the Select Australian Equity Fund and Maple-Brown Abbott's Australian Equity Trust. "Lazard have been public in saying they have felt the resources boom has been overpriced, so they ... |
| | | | ... 210 Queensland Investment Corporation (QIC) 215 ANZ Banking Group Australia 269 Perpetual Ltd Australia 341 Maple-Brown Abbott Ltd 358 Perennial Investment Partners 375 Challenger Financial Services Ltd 397 Insurance Australia Group 403 Lend Lease 406 ... |
| | | | ... headline gross-returns may be. This focus has been championed recently by Vanguard, Navigator, Plan B, van Eyke, Maple-Brown Abbott, and the emerging managed accounts sector. |
| | | | ... the ratings overall. The Navigator survey backs up calls from other industry players, including Vanguard and Maple-Brown Abbott, for a greater focus on after tax performance. |
| | | | Maple-Brown Abbott has announced it will expand its horizons towards more offshore investment, with a 20 per cent allocation to Asia ex-Japan built into its new fund. Maple-Brown Abbott managing director, John Kightley, said the Australia Plus Asia ... |
| | | | ... Asset Management (Advance) has had its Advance Asian Equity Fund upgraded to four stars by S&P. S&P said that Maple-Brown Abbott (MBA), the underlying manager of the fund, continued to leverage its successful investment process into the Asian equity ... |
| | | | ... investment management front, shifting across to Intech has caused the fund to close domestic equities mandates with Maple-Brown Abbott, Schroders, and Perennial, and to close international equities mandates with BGI and Credit Suisse. However other mandates ... |
| | | | ... the allocated pension and TAP products provide up to 29 investment options from Sunsuper, SSgA, AMP, Lazard, Maple-Brown Abbott and QIC, from which investors can choose up to six options. The product offering is a spread of defensive, growth, property ... |
| | | | ... all front shareholders. NEW YORK - US stocks were little changed amid light volume after a drug development setback for Abbott Laboratories offset gains from a flurry of acquisition activity, including the sale of Georgia-Pacific Corp. With no major ... |
| | | | ... Rosenberg's Australian Long Short Equity Fund. The Australian share managers are MIR Investment Management, Maple-Brown Abbott, Investors Mutual and Bernstein Investment Research and Management. The international share managers include Barclays Global ... |
|